The Gujarat government is taking strong action against fake and duplicate medicines. On Tuesday, Health Minister Rushikesh Patel announced plans to create Standard Operating Procedures (SOPs) to improve the detection and seizure of these harmful products. Recently, it was reported that fake medicines are entering Gujarat from outside the state and are being sold at various locations. In response, the Gujarat Food and Drug Control Administration (FDCA) has already conducted on-site inspections to tackle this issue. The new SOPs will require the registration of imported medicines and transporters carrying them. Additionally, licenses of chemists or wholesalers found dealing with fake medicines will be cancelled. This is part of a stricter enforcement of the Drugs and Cosmetics Act, especially for expensive and fast-moving medicines. To support these efforts, the state plans to open three new testing labs, adding to the existing NABL-certified lab in Vadodara. They will also acquire advanced handheld devices called Raman Spectrometers for on-site testing. Furthermore, a flying squad will be formed to enhance monitoring. Patel expressed confidence that these measures will position Gujarat as the first state in India to adopt a ‘zero-tolerance’ policy towards fake medicines. Over the past four years, the government has seized more than Rs 6 crore worth of counterfeit medicines and cosmetics, with approximately 75 individuals and firms facing legal action. Many of those involved do not have valid licenses to buy, sell, or store medicines. Investigations have shown that most counterfeit medicines are sourced from outside the state. The government is committed to taking intensive action to prevent the influx of fake medicines into Gujarat. This crackdown is vital for public health, as counterfeit drugs pose serious risks, including incorrect dosages and harmful substances. The new guidelines aim to ensure that the public can trust the medicines they purchase. This initiative is part of a broader effort to strengthen the pharmaceutical supply chain and protect consumers from health risks associated with counterfeit drugs. The public is encouraged to report any suspicious medicines to the authorities. By enhancing collaboration with central regulatory bodies and other states, Gujarat aims to widen the scope of its efforts against fake medicines. This is a crucial step in safeguarding the health of its citizens and ensuring the integrity of the pharmaceutical market in the state.
